XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements Of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock And Additional Paid-In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Parent [Member]
Noncontrolling Interest [Member]
Class A Common Stock [Member]
Class A Common Stock [Member]
Common Stock And Additional Paid-In Capital [Member]
Class B Common Stock [Member]
Class B Common Stock [Member]
Common Stock And Additional Paid-In Capital [Member]
Preferred Stock [Member]
Common Stock And Additional Paid-In Capital [Member]
Balance (in shares) at Dec. 31, 2020               358,110   3  
Balance at Dec. 31, 2020 $ 26,351.5 $ 21,189.1 $ 4,995.9 $ 134.9 $ 26,319.9            
Balance at Dec. 31, 2020           $ 31.6          
Less: net (income) loss attributable to non-controlling interests (0.7)         (0.7)          
Net Income Attributable to CME Group 1,084.7   1,084.7   1,084.7            
Net Income 1,085.4                    
Other comprehensive income (loss), net of tax (28.9)     (28.9) (28.9)            
Dividends, Cash (646.1)   (646.1)   (646.1)            
Purchase of noncontrolling interest (12.5) (4.4)     (4.4) 8.1          
Exercise of stock options, shares               58      
Exercise of stock options 3.2 3.2     3.2            
Vesting of issued restricted Class A common stock, shares               104      
Vesting of issued restricted Class A common stock (13.5) (13.5)     (13.5)            
Stock Issued During Period, Shares, Issued for Services               13      
Stock Issued During Period, Value, Issued for Services 2.9 2.9     2.9            
Stock Issued During Period, Shares, Employee Stock Purchase Plans               20      
Stock Issued During Period, Value, Employee Stock Purchase Plan 4.4 4.4     4.4            
Stock-based compensation 41.0 41.0     41.0            
Balance (in shares) at Jun. 30, 2021               358,305   3  
Balance at Jun. 30, 2021 26,787.4 21,222.7 5,434.5 106.0 26,763.2            
Balance at Jun. 30, 2021           24.2          
Balance (in shares) at Mar. 31, 2021               358,240   3  
Balance at Mar. 31, 2021 26,555.9 21,197.1 5,247.3 83.5 26,527.9            
Balance at Mar. 31, 2021           28.0          
Less: net (income) loss attributable to non-controlling interests (0.3)         (0.3)          
Net Income Attributable to CME Group 510.3   510.3   510.3            
Net Income 510.6                    
Other comprehensive income (loss), net of tax 22.5     22.5 22.5            
Dividends, Cash (323.1)   (323.1)   (323.1)            
Purchase of noncontrolling interest (6.3) (2.2)     (2.2) 4.1          
Exercise of stock options, shares               27      
Exercise of stock options 1.5 1.5     1.5            
Vesting of issued restricted Class A common stock, shares               5      
Vesting of issued restricted Class A common stock (0.4) (0.4)     (0.4)            
Stock Issued During Period, Shares, Issued for Services               13      
Stock Issued During Period, Value, Issued for Services 2.9 2.9     2.9            
Stock Issued During Period, Shares, Employee Stock Purchase Plans               20      
Stock Issued During Period, Value, Employee Stock Purchase Plan 4.4 4.4     4.4            
Stock-based compensation 19.4 19.4     19.4            
Balance (in shares) at Jun. 30, 2021               358,305   3  
Balance at Jun. 30, 2021 26,787.4 21,222.7 5,434.5 106.0 26,763.2            
Balance at Jun. 30, 2021           $ 24.2          
Balance (in shares) at Dec. 31, 2021             358,599 358,599 3 3 4,584
Balance at Dec. 31, 2021 27,399.3 22,193.9 5,151.9 53.5 27,399.3            
Less: net (income) loss attributable to non-controlling interests 0.0                    
Net Income Attributable to CME Group 1,373.5   1,373.5   1,373.5            
Net Income 1,373.5                    
Other comprehensive income (loss), net of tax (85.2)     (85.2) (85.2)            
Dividends, Cash     (727.9)   (727.9)            
Exercise of stock options, shares               1      
Exercise of stock options   0.1     0.1            
Vesting of issued restricted Class A common stock, shares               39      
Vesting of issued restricted Class A common stock   (5.3)     (5.3)            
Stock Issued During Period, Shares, Issued for Services               19      
Stock Issued During Period, Value, Issued for Services   4.0     4.0            
Stock Issued During Period, Shares, Employee Stock Purchase Plans               19      
Stock Issued During Period, Value, Employee Stock Purchase Plan   3.8     3.8            
Stock-based compensation   39.4     39.4            
Balance (in shares) at Jun. 30, 2022             358,677 358,677 3 3 4,584
Balance at Jun. 30, 2022 28,001.7 22,235.9 5,797.5 (31.7) 28,001.7            
Balance (in shares) at Mar. 31, 2022               358,631   3 4,584
Balance at Mar. 31, 2022   22,209.9 5,498.9 28.0 27,736.8            
Less: net (income) loss attributable to non-controlling interests 0.0                    
Net Income Attributable to CME Group 662.5   662.5   662.5            
Net Income 662.5                    
Other comprehensive income (loss), net of tax (59.7)     (59.7) (59.7)            
Dividends, Cash     (363.9)   (363.9)            
Exercise of stock options, shares               1      
Exercise of stock options   0.1     0.1            
Vesting of issued restricted Class A common stock, shares               8      
Vesting of issued restricted Class A common stock   (1.0)     (1.0)            
Stock Issued During Period, Shares, Issued for Services               18      
Stock Issued During Period, Value, Issued for Services   3.7     3.7            
Stock Issued During Period, Shares, Employee Stock Purchase Plans               19      
Stock Issued During Period, Value, Employee Stock Purchase Plan   3.8     3.8            
Stock-based compensation   19.4     19.4            
Balance (in shares) at Jun. 30, 2022             358,677 358,677 3 3 4,584
Balance at Jun. 30, 2022 $ 28,001.7 $ 22,235.9 $ 5,797.5 $ (31.7) $ 28,001.7